SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001162
Filing Date
2019-09-11
Accepted
2019-09-11 06:01:48
Documents
13
Period of Report
2019-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529194_8k.htm   iXBRL 8-K 25873
2 EXHIBIT 99.1 tv529194_ex99-1.htm EX-99.1 6106
  Complete submission text file 0001410578-19-001162.txt   203358

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20190911.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20190911_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20190911_pre.xml EX-101.PRE 21957
14 EXTRACTED XBRL INSTANCE DOCUMENT tv529194_8k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 191087123
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1